SUNRISE, again a control arm outperforming incident while bavituximab performed well.
Right, CP, right. It is now about 6 months after Sunrise was stopped at the first futility look-in and the same time frame since PPHM made the vague claims about both the control arm and the Bavi + DOC arm. You have to ask yourself why didn't PPHM provide the numbers then that supposedly supported that vague comment at the tie it was first issued. There is no reason I can think of except is was a desperate attempt at spin in the face of an overwhelming failure. You also have to ask yourself if that vague claim was valid, why hasn't PPHM make it more forcefully and repeatedly now, and why they haven't provided the numbers now.